Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect F...

por Xu, Ru-jun, Kong, Wei-min, An, Xiao-fei, Zou, Jian-jun, Liu, Li, Liu, Xiao-dong
Publicado 2020

Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibi...

por Zou, Jian-Jun, Chen, Shao-Liang, Tan, Jie, Lin, Ling, Zhao, Ying-Ying, Xu, Hai-Mei, Lin, Song, Zhang, Juan, Fan, Hong-Wei, Xie, Hong-Guang
Publicado 2014

The association between smoking and unfavorable outcomes in acute ischemic stroke patients with mechanical thrombectomy

por Zhao, Zhihong, Zhao, Zheng, Zheng, Xiaohan, Li, Xiang, Li, Xuemei, Huang, Chaoping, Shan, Yajie, Nyame, Linda, Ibrahim, Mako, Gao, Xiaoping, Liang, Hui, Hu, Jue, Zou, JianJun
Publicado 2020

Development and External Validation of a Dynamic Nomogram With Potential for Risk Assessment of Ruptured Multiple Intracranial Aneurysms

por Chen, TingTing, Xiong, WeiGen, Zhao, ZhiHong, Shan, YaJie, Li, XueMei, Guo, LeHeng, Xiang, Lan, Chu, Dong, Fan, HongWei, Li, YingBin, Zou, JianJun
Publicado 2022

A visualized nomogram to online predict futile recanalization after endovascular thrombectomy in basilar artery occlusion stroke

por Lin, ShiTeng, Lin, XinPing, Zhang, Juan, Wan, Meng, Chen, Chen, Jie, Qiong, Wu, YueZhang, Qiu, RunZe, Cui, XiaoLi, Jiang, ChunLian, Zou, JianJun, Zhao, ZhiHong
Publicado 2022

A novel visual dynamic nomogram to online predict the risk of unfavorable outcome in elderly aSAH patients after endovascular coiling: A retrospective study

por Lu, Wei, Tong, YuLan, Zhang, Cheng, Xiang, Lan, Xiang, Liang, Chen, Chen, Guo, LeHeng, Shan, YaJie, Li, XueMei, Zhao, Zheng, Pan, XiDing, Zhao, ZhiHong, Zou, JianJun
Publicado 2023

A visualized MAC nomogram online predicts the risk of three-month mortality in Chinese elderly aneurysmal subarachnoid hemorrhage patients undergoing endovascular coiling

por Zhou, Zhou, Lu, Wei, Zhang, Cheng, Xiang, Lan, Xiang, Liang, Chen, Chen, Wang, BiJun, Guo, LeHeng, Shan, YaJie, Li, XueMei, Zhao, Zheng, Zou, JianJun, Dai, XiaoMing, Zhao, ZhiHong
Publicado 2023

Predicting 6-Month Unfavorable Outcome of Acute Ischemic Stroke Using Machine Learning

por Li, Xiang, Pan, XiDing, Jiang, ChunLian, Wu, MingRu, Liu, YuKai, Wang, FuSang, Zheng, XiaoHan, Yang, Jie, Sun, Chao, Zhu, YuBing, Zhou, JunShan, Wang, ShiHao, Zhao, Zheng, Zou, JianJun
Publicado 2020

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing

por Su, Shan, Zou, Jian-Jun, Zeng, Yun-Yun, Cen, Wen-Chang, Zhou, Wei, Liu, Yan, Su, Duo-Hua, Zhang, Xian-Lan, Huang, Hui-Yi, Lei, An, Huang, Zhi-Hao, Jin, Yun, Li, Lei, Su, Ning, Xie, Ya-Lin, Zhao, Zhen-Gang, Liu, Jian-Xiong
Publicado 2019

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis

por Ye, Mei-Feng, Su, Shan, Huang, Zhi-Hao, Zou, Jian-Jun, Su, Duo-Hua, Chen, Xiao-Hui, Zeng, Long-Feng, Liao, Wei-Xiang, Huang, Hui-Yi, Zeng, Yun-Yun, Cen, Wen-Chang, Zhang, Xian-Lan, Liao, Chun-Xin, Zhang, Jian, Zhang, Yan-Bin
Publicado 2020

Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

por Su, Shan, Ye, Mei-Feng, Cai, Xiao-Ting, Bai, Xue, Huang, Zhi-Hao, Ma, Si-Cong, Zou, Jian-Jun, Wen, Yu-Xiang, Wu, Li-Juan, Guo, Xue-Jun, Zhang, Xian-Lan, Cen, Wen-Chang, Su, Duo-Hua, Huang, Hui-Yi, Dong, Zhong-Yi
Publicado 2021

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

por Wu, Song-Yang, Xu, Ying, Chen, Li, Fan, Lei, Ma, Xiao-Yan, Zhao, Shen, Song, Xiao-Qing, Hu, Xin, Yang, Wen-Tao, Chai, Wen-Jun, Guo, Xiao-Mao, Chen, Xi-Zi, Xu, Yan-Hui, Zhu, Xiao-Yu, Zou, Jian-Jun, Wang, Zhong-Hua, Jiang, Yi-Zhou, Shao, Zhi-Ming
Publicado 2022

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

por Chen, Li, Jiang, Yi-Zhou, Wu, Song-Yang, Wu, Jiong, Di, Gen-Hong, Liu, Guang-Yu, Yu, Ke-Da, Fan, Lei, Li, Jun-Jie, Hou, Yi-Feng, Hu, Zhen, Chen, Can-Ming, Huang, Xiao-Yan, Cao, A-Yong, Hu, Xin, Zhao, Shen, Ma, Xiao-Yan, Xu, Ying, Sun, Xiang-Jie, Chai, Wen-Jun, Guo, Xiaomao, Chen, Xizi, Xu, Yanhui, Zhu, Xiao-Yu, Zou, Jian-Jun, Yang, Wen-Tao, Wang, Zhong-Hua, Shao, Zhi-Ming
Publicado 2022